FA
STIM icon

Friess Associates’s Neuronetics STIM Stock Holding History

Friess Associates’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-291,700
Closed -$4.67M – 107
2021
Q2 		$4.67M Sell
291,700
-147,267
-34% -$2.03M 1.76% 21
2021
Q1 		$5.43M Sell
438,967
-80,635
-16% -$1.24M 2.11% 11
2020
Q4 		$5.77M Buy
+519,602
New +$3.91M 0.43% 55
2019
Q2 		– Sell
-63,983
Closed -$976K – 140
2019
Q1 		$976K Sell
63,983
-177,301
-73% -$2.93M 0.07% 112
2018
Q4 		$4.67M Buy
241,284
+197,712
+454% +$4.34M 0.4% 75
2018
Q3 		$1.4M Buy
43,572
+18,572
+74% +$565K 0.1% 100
2018
Q2 		$665K Buy
+25,000
New +$680K 0.05% 105

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Friess Associates's STIM Position: Q3 2021 in Review

Friess Associates sold out of Neuronetics (STIM) in Q3 2021, closing a stake of 291,700 shares — an estimated $4.67M sold.

Friess Associates first reported a position in STIM in Q2 2018 and held it in 7 quarters. The position peaked at $5.77M in Q4 2020. 97 funds tracked by Wall St. Rank hold STIM as of Q3 2021.

  • Friess Associates reported no remaining Neuronetics position as of Q3 2021 after selling out during the quarter.
  • Friess Associates sold 291,700 Neuronetics shares in Q3 2021, an estimated $4.67M.
  • Friess Associates first reported a position in Neuronetics in Q2 2018 and held it in 7 quarters.
  • Friess Associates's Neuronetics position peaked at $5.77M in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Neuronetics as of Q3 2021.

Based on Friess Associates's 13F filing for Q3 2021, filed 12 Nov 2021.